Aldevron vs Charles River Laboratories: CDMO Comparison
Side-by-side comparison of Aldevron and Charles River Laboratories on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Charles River Laboratories has more FDA inspections on record (7 vs 1) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Charles River Laboratories holds 9 active EMA GMP certificates; Aldevron does not appear in EudraGMDP.
- Charles River Laboratories maintains 2 MHRA / UK GMP certificates; Aldevron does not.
On a 13-modality CDMO landscape, both Aldevron and Charles River Laboratories qualify as Plasmid DNA manufacturers; Charles River Laboratories carries the higher composite Signal Score for Plasmid DNA programs in this comparison.
What to evaluate for Plasmid DNA programs
Both Aldevron and Charles River Laboratories qualify as Plasmid DNA CDMOs. When choosing between them for Plasmid DNA programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
GMP grade & purity
Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality.
Fermentation scale & yield
Match fermentation scale and yield to your vector or mRNA demand. Ask about high-yield strains and whether scale-up is validated.
Lead time
Plasmid is a common critical-path bottleneck. Evaluate realistic queue and turnaround against your program timeline.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.
Frequently asked: Aldevron vs Charles River Laboratories
Which has the stronger FDA inspection record, Aldevron or Charles River Laboratories?
Both Aldevron and Charles River Laboratories maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Aldevron has 1 FDA inspection on record; Charles River Laboratories has 7.
How do Aldevron and Charles River Laboratories compare on European GMP coverage?
Aldevron holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Charles River Laboratories holds 9 active EMA GMP certificates and 2 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is better for Plasmid DNA manufacturing — Aldevron or Charles River Laboratories?
Both Aldevron and Charles River Laboratories are tagged as Plasmid DNA CDMOs in our directory, so both are credible options for Plasmid DNA programs. The most important differentiator for Plasmid DNA selection is typically gmp grade & purity: Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Aldevron carries a Signal Score of 85/100 and Charles River Laboratories carries 92/100 — a small lead for Charles River Laboratories. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →